ASCO Annual Meeting

Conference Coverage

Featured

CONFERENCE COVERAGE
CONFERENCE COVERAGE
06/10/2026
Ashton L. Stahl
Researchers assessed whether GLP-1 exposure was associated with breast cancer incidence among women undergoing screening.
06/10/2026
2026 ASCO Annual Meeting
2026 ASCO Annual Meeting
06/04/2026
Anthony Calabro, MA
In the phase 3 RASolute 302 trial, daraxonrasib improved overall survival and progression-free survival vs chemotherapy in patients with second-line metastatic pancreatic adenocarcinoma.
06/04/2026
2026 ASCO ANNUAL MEETING
2026 ASCO ANNUAL MEETING
06/04/2026
Anthony Calabro, MA
In a retrospective national VA cohort of nearly 1 million Veterans, tobacco smoking duration criteria identified more screening-eligible patients and fewer missed lung cancer diagnoses than pack-year...
06/04/2026

More

CONFERENCE COVERAGE
CONFERENCE COVERAGE
06/10/2026
Ashton L. Stahl
Researchers assessed whether GLP-1 exposure was associated with breast cancer incidence among women undergoing screening.
06/10/2026
2026 ASCO Annual Meeting
2026 ASCO Annual Meeting
06/04/2026
Anthony Calabro, MA
In the phase 3 RASolute 302 trial, daraxonrasib improved overall survival and progression-free survival vs chemotherapy in patients with second-line metastatic pancreatic adenocarcinoma.
06/04/2026
2026 ASCO ANNUAL MEETING
2026 ASCO ANNUAL MEETING
06/04/2026
Anthony Calabro, MA
In a retrospective national VA cohort of nearly 1 million Veterans, tobacco smoking duration criteria identified more screening-eligible patients and fewer missed lung cancer diagnoses than pack-year...
06/04/2026
ASCO CONFERENCE COVERAGE
ASCO CONFERENCE COVERAGE
05/26/2026
Anthony Calabro, MA
In a phase 3 randomized trial of women with stage I-III breast cancer, a low-glycemic Mediterranean diet, brisk walking, and vitamin D did not reduce recurrence overall but improved weight and metabolic...
05/26/2026
ASCO CONFERENCE COVERAGE
ASCO CONFERENCE COVERAGE
05/22/2026
Anthony Calabro, MA
In a propensity-matched analysis of stage I-III solid tumors, GLP-1 receptor agonist exposure after cancer diagnosis was associated with lower metastatic progression in several cancer types. These findings...
05/22/2026